FoxO1 protects the heart against ischemia
FoxO1 保护心脏免受缺血
基本信息
- 批准号:10443714
- 负责人:
- 金额:$ 57.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAddressAffinityApoptosisApoptoticArrhythmiaAutophagocytosisBindingCCAAT-Enhancer-Binding ProteinsCardiacCardiac MyocytesCell DeathCell MaintenanceCell NucleusCell SurvivalCell physiologyCellsCessation of lifeClinicalComplexConsensusDNA BindingDNA Binding DomainDevelopmentDissociationElementsFOXO1A geneFamilyFeedbackGene DeliveryGenesGenetic TranscriptionHeartHeart failureHomodimerizationInsulin ResistanceInterventionInvestigationIschemiaKnock-in MouseKnock-outKnowledgeLeadManganeseMediatingMolecularMusMyocardialMyocardial InfarctionMyocardial IschemiaMyocardial ReperfusionOxidative StressPMAIP1 genePathway interactionsPatientsPhosphorylationPhosphotransferasesPhysiologicalPhysiologyPlayProteinsProteomicsRegulationReperfusion TherapyRoleSIRT1 geneSerineStarvationSterilityStimulusStressSuperoxide DismutaseTNFSF10 geneTestingThreoninecardioprotectioncatalaseinnovationmouse modelmyocardial injurynovelperoxiredoxin 2postnatalpromoterresponsetranscription factor
项目摘要
Summary
Forkhead box protein O (FoxO) family transcription factors are evolutionarily conserved proteins that play
essential roles during development and in postnatal physiology in the heart. FoxOs play a dichotomous role in
the regulation of cell survival/death in a context-dependent manner: they mediate cardiomyocyte (CM) cell
death under some conditions but promote cell survival under other conditions. FoxOs can promote cell death
by stimulating transcription of Bim, TRAIL, FasL, Bcl-6 and NOXA or lead to insulin resistance by
downregulating IRS. On the other hand, endogenous FoxOs promote CM survival in response to oxidative
stress and mediate the pro-survival effects of Sirt1 in CMs during ischemia/reperfusion (I/R). Moreover, FoxO1-
dependent transcription of autophagy genes is required for survival of CMs during starvation. At present,
however, how FoxOs mediate their dichotomous cellular functions is not well understood. Better understanding
of the underlying mechanisms may make it possible to promote only the salutary function of FoxO1 while
inhibiting the pro-death function of FoxO1 in the heart in the clinical setting. Our preliminary results suggest
that Mst1, a pro-apoptotic kinase, can convert FoxO1 from pro-apoptotic to pro-survival through sequential
phosphorylation of FoxO1 and C/EBP- in CMs. Our overall hypothesis is that Mst1 converts the function of
the transcription factor FoxO1 from pro-apoptotic to pro-survival through sequential phosphorylation of FoxO1
at the DNA binding domain (DBD) and C/EBP-at Thr250 (mouse). We will: Aim 1 Show that FoxO1
promotes CM survival during myocardial ischemia and I/R through Mst1-induced phosphorylation of at
the DBD; Aim 2 Demonstrate that Mst1 induces dissociation of FoxO1 from the promoter of pro-
apoptotic FoxO target genes and association with C/EBP- to promote transcription of pro-survival
molecules; Aim 3 Demonstrate that Mst1-induced phosphorylation of C/EBP- at Thr250 is FoxO1-
dependent, and that Thr250 phosphorylation of C/EBP- promotes transcription of pro-survival factors;
Aim 4 Demonstrate that C/EBP- phosphorylation at Thr250 is salutary and plays an essential role in
mediating the salutary effect of the Mst1-FoxO1 pathway during ischemia and I/R. We will use cardiac-
specific FoxO1 knockout (KO) (FoxO1cKO) and cardiac-specific C/EBP- KO (C/EBP- cKO) mice, as well as
newly generated C/EBP- (T250E) knock-in (KI) mice in conjunction with AAV-mediated gene delivery and
proteomics. Our study will elucidate the molecular mechanism by which FoxO transcription factors regulate
directionally opposite cellular functions, namely survival and death, in a coordinated manner and through
interaction with Mst1 and C/EBP-. Knowledge obtained from this study should be useful for the development
of molecular interventions to convert the function of FoxO transcription factors from dichotomous to fully
cardioprotective and facilitate survival of CMs in the setting of myocardial injury.
总结
叉头盒蛋白O(FoxO)家族转录因子是进化上保守的蛋白质,
心脏在发育和出生后生理过程中的重要作用。FoxO在以下方面发挥着双重作用:
以环境依赖方式调节细胞存活/死亡:它们介导心肌细胞(CM)细胞
在某些条件下死亡,但在其他条件下促进细胞存活。FoxOs可以促进细胞死亡
通过刺激Bim、TRAIL、FasL、Bcl-6和NOXA的转录,或通过
下调IRS。另一方面,内源性FoxO促进CM存活以响应氧化应激。
应激和介导Sirt 1在缺血/再灌注(I/R)期间CM中的促存活作用。此外,FoxO 1-
自噬基因的依赖性转录是饥饿期间CM存活所必需的。目前,
然而,FoxO如何介导其二分细胞功能尚不清楚。更好地理解
潜在的机制可能只促进FoxO 1的有益功能,
在临床环境中抑制心脏中FoxO 1的促死亡功能。我们的初步结果表明
Mst 1是一种促凋亡激酶,它可以通过顺序性地将FoxO 1从促凋亡转化为促存活,
CM中FoxO 1和C/EBP-beta的磷酸化。我们的总体假设是,Mst 1转换了
转录因子FoxO 1通过FoxO 1顺序磷酸化从促凋亡到促存活
在DNA结合结构域(DBD)和在Thr 250(小鼠)的C/EBP-结合酶。我们将:目标1显示FoxO 1
在心肌缺血和I/R期间通过Mst 1诱导at磷酸化促进CM存活
目的2证明Mst 1诱导FoxO 1从原-
凋亡FoxO靶基因及其与C/EBP-β的相关性,以促进促存活基因的转录
目的3证明Mst 1诱导的C/EBP-γ在Thr 250的磷酸化是FoxO 1-
C/EBP-β的Thr 250磷酸化促进促存活因子的转录;
目的4证明Thr 250的C/EBP-1磷酸化是有益的,并在细胞凋亡中起重要作用。
介导缺血和I/R期间Mst 1-FoxO 1通路的有益作用。我们会用心脏-
特异性FoxO 1敲除(KO)(FoxO 1cKO)和心脏特异性C/EBP-KO(C/EBP-KO)小鼠,以及
新产生的C/EBP-100(T250 E)敲入(KI)小鼠与AAV介导的基因递送结合,
蛋白质组学我们的研究将阐明FoxO转录因子调控的分子机制
相反的细胞功能,即生存和死亡,以协调的方式,并通过
与Mst 1和C/EBP-1相互作用。从这项研究中获得的知识应该有助于发展
将FoxO转录因子的功能从二分型转变为完全型的分子干预
心脏保护和促进CM在心肌损伤情况下的存活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Junichi Sadoshima其他文献
Junichi Sadoshima的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Junichi Sadoshima', 18)}}的其他基金
PPARα induces IL-6 to trigger diabetic cardiomyopathy
PPARα 诱导 IL-6 引发糖尿病心肌病
- 批准号:
10317052 - 财政年份:2019
- 资助金额:
$ 57.52万 - 项目类别:
PPARα induces IL-6 to trigger diabetic cardiomyopathy
PPARα 诱导 IL-6 引发糖尿病心肌病
- 批准号:
10534143 - 财政年份:2019
- 资助金额:
$ 57.52万 - 项目类别:
PPARα induces IL-6 to trigger diabetic cardiomyopathy
PPARα 诱导 IL-6 引发糖尿病心肌病
- 批准号:
9902080 - 财政年份:2019
- 资助金额:
$ 57.52万 - 项目类别:
PPARα induces IL-6 to trigger diabetic cardiomyopathy
PPARα 诱导 IL-6 引发糖尿病心肌病
- 批准号:
10062516 - 财政年份:2019
- 资助金额:
$ 57.52万 - 项目类别:
Removal of damaged mitochondria by alternative autophagy
通过替代自噬去除受损的线粒体
- 批准号:
10630824 - 财政年份:2017
- 资助金额:
$ 57.52万 - 项目类别:
Removal of damaged mitochondria by alternative autophagy
通过替代自噬去除受损的线粒体
- 批准号:
10305935 - 财政年份:2017
- 资助金额:
$ 57.52万 - 项目类别:
Removal of damaged mitochondria by alternative autophagy
通过替代自噬去除受损的线粒体
- 批准号:
10452680 - 财政年份:2017
- 资助金额:
$ 57.52万 - 项目类别:
Removal of damaged mitochondria by alternative autophagy
通过替代自噬去除受损的线粒体
- 批准号:
9978602 - 财政年份:2017
- 资助金额:
$ 57.52万 - 项目类别:
REGULATION OF MYOCARDIAL GROWTH AND DEATH BY THE HIPPO PATHWAY
HIPPO 通路对心肌生长和死亡的调节
- 批准号:
8764135 - 财政年份:2013
- 资助金额:
$ 57.52万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 57.52万 - 项目类别:
Research Grant